Trial shows York leishmaniasis vaccine safe and induces immune responses in patients

Unique U.S. Army Developed COVID-19 Vaccine Begins Phase 1 Clinical Trial

C.D.C. Panel Keeps Pause on Use of J&J Vaccine, Weighing Risks

How The Johnson & Johnson Vaccine Pause Might Slow Down The Global Covid-19 Response